Once is not enough: clinical trials in sepsis

被引：35
作者：
Sweeney, Daniel A. [1 ]
Danner, Robert L. [1 ]
Eichacker, Peter Q. [1 ]
Natanson, Charles [1 ]
机构：
[1] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA
来源：
INTENSIVE CARE MEDICINE | 2008年 / 34卷 / 11期
关键词：
D O I：
10.1007/s00134-008-1274-6
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1955 / 1960
页数：6
相关论文
共 48 条
  • [1] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
    Abraham, E
    Laterre, P
    Garg, R
    Levy, H
    Talwar, D
    Trzaskoma, BL
    Francois, B
    Guy, JS
    Bruckmann, M
    Rea-Neto, A
    Rossaint, R
    Perrotin, D
    Sablotzki, A
    Arkins, N
    Utterback, BG
    Macias, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341
  • [2] Alejandria MM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001090
  • [3] [Anonymous], 1963, JAMA
  • [4] BAUMGARTNER JD, 1985, LANCET, V2, P59
  • [5] Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis
    Bernard, GR
    Ely, EW
    Wright, TJ
    Fraiz, J
    Stasek, JE
    Russell, JA
    Mayers, I
    Rosenfeld, BA
    Morris, PE
    Yan, SB
    Helterbrand, JD
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (11) : 2051 - 2059
  • [6] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [7] Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey
    Bertolini, Guido
    Rossi, Carlotta
    Anghileri, Abramo
    Livigni, Sergio
    Addis, Antonio
    Poole, Daniele
    [J]. INTENSIVE CARE MEDICINE, 2007, 33 (03) : 426 - 434
  • [8] A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TO ENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL
    BONE, RC
    BALK, RA
    FEIN, AM
    PERL, TM
    WENZEL, RP
    REINES, HD
    QUENZER, RW
    IBERTI, TJ
    MACINTYRE, N
    SCHEIN, RMH
    TRENHOLME, G
    NIEDERMAN, M
    CHALFIN, D
    ABALOS, A
    OROPELLO, J
    EMPSON, P
    CAMINITII, S
    GREENMAN, R
    BOOTH, F
    PLOUFFE, J
    RUSSELL, J
    GIANAKOPOULOS, G
    IANNINI, P
    HINDES, R
    COBLENS, K
    KOHLER, R
    MARTIN, M
    BERNARD, G
    EDWARDS, J
    CRISLIP, M
    FILLER, S
    NASRAWAY, SA
    SIGEL, PK
    SOTTILE, FD
    MARTIN, DH
    DEBOISBLANC, BP
    CHANDRASEKAR, PH
    BROUGHTON, WA
    MIDDLETON, RM
    SEIBERT, AF
    EMMANUEL, G
    LIE, TH
    ANDERSON, CLV
    PANKEY, GA
    ANDERSON, P
    OLSEN, K
    SANPEDRO, GS
    GRAHAM, D
    GROSSMAN, J
    WELS, PB
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (06) : 994 - 1006
  • [9] A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) : 653 - 658
  • [10] Intensive insulin therapy and pentastarch resuscitation in severe sepsis
    Brunkhorst, Frank M.
    Engel, Christoph
    Bloos, Frank
    Meier-Hellmann, Andreas
    Ragaller, Max
    Weiler, Norbert
    Moerer, Onnen
    Gruendling, Matthias
    Oppert, Michael
    Grond, Stefan
    Olthoff, Derk
    Jaschinski, Ulrich
    John, Stefan
    Rossaint, Rolf
    Welte, Tobias
    Schaefer, Martin
    Kern, Peter
    Kuhnt, Evelyn
    Kiehntopf, Michael
    Hartog, Christiane
    Natanson, Charles
    Loeffler, Markus
    Reinhart, Konrad
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) : 125 - 139
12345